The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma
about
Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells.The Landscape of Small Non-Coding RNAs in Triple-Negative Breast Cancer.New cGMP analogues restrain proliferation and migration of melanoma cells.Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents.
P2860
The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The cyclic GMP/protein kinase ...... d neck squamous cell carcinoma
@ast
The cyclic GMP/protein kinase ...... d neck squamous cell carcinoma
@en
type
label
The cyclic GMP/protein kinase ...... d neck squamous cell carcinoma
@ast
The cyclic GMP/protein kinase ...... d neck squamous cell carcinoma
@en
prefLabel
The cyclic GMP/protein kinase ...... d neck squamous cell carcinoma
@ast
The cyclic GMP/protein kinase ...... d neck squamous cell carcinoma
@en
P2093
P2860
P1433
P1476
The cyclic GMP/protein kinase ...... d neck squamous cell carcinoma
@en
P2093
Michelle L Mierzwa
Sejal R Fox
Susanne I Wells
Traci R Tuttle
P2860
P304
P356
10.1016/J.CANLET.2015.10.024
P407
P577
2015-11-06T00:00:00Z